462 related articles for article (PubMed ID: 17069793)
1. Intestinal effects of nonselective and selective cyclooxygenase inhibitors in the rat.
Menozzi A; Pozzoli C; Giovannini E; Solenghi E; Grandi D; Bonardi S; Bertini S; Vasina V; Coruzzi G
Eur J Pharmacol; 2006 Dec; 552(1-3):143-50. PubMed ID: 17069793
[TBL] [Abstract][Full Text] [Related]
2. Role of cyclooxygenase (COX)-1 and COX-2 inhibition in nonsteroidal anti-inflammatory drug-induced intestinal damage in rats: relation to various pathogenic events.
Tanaka A; Hase S; Miyazawa T; Ohno R; Takeuchi K
J Pharmacol Exp Ther; 2002 Dec; 303(3):1248-54. PubMed ID: 12438549
[TBL] [Abstract][Full Text] [Related]
3. Influence of cyclooxygenase inhibitors on gut immune cell distribution and apoptosis rate in experimental sepsis.
Osterberg J; Ljungdahl M; Haglund U
Shock; 2006 Feb; 25(2):147-54. PubMed ID: 16525353
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic treatment with ampicillin accelerates the healing of colonic damage impaired by aspirin and coxib in the experimental colitis. Importance of intestinal bacteria, colonic microcirculation and proinflammatory cytokines.
Zwolinska-Wcislo M; Krzysiek-Maczka G; Ptak-Belowska A; Karczewska E; Pajdo R; Sliwowski Z; Urbanczyk K; Drozdowicz D; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Jun; 62(3):357-68. PubMed ID: 21893697
[TBL] [Abstract][Full Text] [Related]
5. NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same?
Fornai M; Antonioli L; Colucci R; Pellegrini C; Giustarini G; Testai L; Martelli A; Matarangasi A; Natale G; Calderone V; Tuccori M; Scarpignato C; Blandizzi C
J Pharmacol Exp Ther; 2014 Jan; 348(1):86-95. PubMed ID: 24135073
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.
Rainsford KD; Stetsko PI; Sirko SP; Debski S
J Pharm Pharmacol; 2003 May; 55(5):661-8. PubMed ID: 12831509
[TBL] [Abstract][Full Text] [Related]
7. Roles of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Kato S; Amagase K; Satoh H
Clin Chim Acta; 2010 Apr; 411(7-8):459-66. PubMed ID: 20074562
[TBL] [Abstract][Full Text] [Related]
8. Gastric acid is the key modulator in the pathogenesis of non-steroidal anti-inflammatory drug-induced ulceration in rats.
Zinkievich JM; George S; Jha S; Nandi J; Levine RA
Clin Exp Pharmacol Physiol; 2010 Jul; 37(7):654-61. PubMed ID: 20082628
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of both COX-1 and COX-2 and resulting decrease in the level of prostaglandins E2 is responsible for non-steroidal anti-inflammatory drug (NSAID)-dependent exacerbation of colitis.
Tanaka K; Suemasu S; Ishihara T; Tasaka Y; Arai Y; Mizushima T
Eur J Pharmacol; 2009 Jan; 603(1-3):120-32. PubMed ID: 19101538
[TBL] [Abstract][Full Text] [Related]
10. Functional mechanism underlying cyclooxygenase-2 expression in rat small intestine following administration of indomethacin: relation to intestinal hypermotility.
Tanaka A; Matsumoto M; Hayashi Y; Takeuchi K
J Gastroenterol Hepatol; 2005 Jan; 20(1):38-45. PubMed ID: 15610444
[TBL] [Abstract][Full Text] [Related]
11. Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats.
Um SY; Chung MW; Kim KB; Kim SH; Oh JS; Oh HY; Lee HJ; Choi KH
Anal Chem; 2009 Jun; 81(12):4734-41. PubMed ID: 19462990
[TBL] [Abstract][Full Text] [Related]
12. Ulcerogenic influence of selective cyclooxygenase-2 inhibitors in the rat stomach with adjuvant-induced arthritis.
Kato S; Ogawa Y; Kanatsu K; Okayama M; Watanabe T; Arakawa T; Takeuchi K
J Pharmacol Exp Ther; 2002 Nov; 303(2):503-9. PubMed ID: 12388629
[TBL] [Abstract][Full Text] [Related]
13. Selective cyclooxygenase (COX) inhibition causes damage to portal hypertensive gastric mucosa: roles of nitric oxide and NF-kappaB.
Akahoshi T; Tanigawa T; Sarfeh IJ; Chiou SK; Hashizume M; Maehara Y; Jones MK
FASEB J; 2005 Jul; 19(9):1163-5. PubMed ID: 15845610
[TBL] [Abstract][Full Text] [Related]
14. Role of COX inhibition in pathogenesis of NSAID-induced small intestinal damage.
Takeuchi K; Tanaka A; Ohno R; Yokota A
J Physiol Pharmacol; 2003 Dec; 54 Suppl 4():165-82. PubMed ID: 15075458
[TBL] [Abstract][Full Text] [Related]
15. Induction of small intestinal damage in rats following combined treatment with cyclooxygenase-2 and nitric-oxide synthase inhibitors.
Ohno R; Yokota A; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2004 Aug; 310(2):821-7. PubMed ID: 15044560
[TBL] [Abstract][Full Text] [Related]
16. [Celecoxib vs indomethacin and acute gastric lesions in rats].
Laudanno OM; Esnarriaga JM; Cesolari JA; Maglione CB; Aramberry LJ; Sambrano JS; Piombo G; Rista L
Medicina (B Aires); 2000; 60(2):221-4. PubMed ID: 10962812
[TBL] [Abstract][Full Text] [Related]
17. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
18. Diazoxide attenuates indomethacin-induced small intestinal damage in the rat.
Menozzi A; Pozzoli C; Poli E; Passeri B; Gianelli P; Bertini S
Eur J Pharmacol; 2011 Jan; 650(1):378-83. PubMed ID: 20950601
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat.
Tibble JA; Sigthorsson G; Foster R; Bjarnason I
Scand J Gastroenterol; 2000 Aug; 35(8):802-7. PubMed ID: 10994617
[TBL] [Abstract][Full Text] [Related]
20. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis.
Kuroda M; Yoshida N; Ichikawa H; Takagi T; Okuda T; Naito Y; Okanoue T; Yoshikawa T
Int J Mol Med; 2006 Jan; 17(1):89-93. PubMed ID: 16328016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
